[Seroxat combined with Meravean--increased risk of hemorrhage?].
Haukeland
J W
JW
D000925:Anticoagulants / Q000009:adverse effects*; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D017374:Paroxetine / Q000009:adverse effects*; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D014859:Warfarin / Q000009:adverse effects*
D000925:Anticoagulants; D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D014859:Warfarin